Home › Non-Small Cell Lung Cancer › New York › Brooklyn
Non-Small Cell Lung Cancer clinical trials in Brooklyn, NY
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Brooklyn (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Maimonides Medical Center, Brooklyn
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Maimonides Cancer Center, Brooklyn
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 3
- Research Site, Brooklyn
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- NYU Langone Hospital - Brooklyn, Brooklyn
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Brooklyn
- Breast Cancer11 studies
- Major Depressive Disorder9 studies
- Type 2 Diabetes7 studies
- Prostate Cancer6 studies
- Obesity6 studies
- Heart Failure6 studies
- Ischemic Stroke5 studies
- Depression5 studies
- Cardiovascular Disease5 studies
- Coronary Artery Disease5 studies
- Metastatic Cancer5 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.